Recruitment Focus Part 2: How Brexit Is Threatening UK Companies’ Ability To Attract Sufficient Regulatory Talent
Medtech stakeholders are frantically stepping up recruitment efforts in order to have the human resources to implement the new EU Medical Device and IVD Regulations on time. But the UK has serious obstacles in its way of its own making. This is Part 2 of a three-part focus on the impact of the new regulations on recruitment in the EU.
You may also be interested in...
Eighteen years of free trade threatens to come to a sudden stop, as a result of the stalemate in the market access agreement between Switzerland and the EU. Industry association Swiss Medtech is advising local medtech manufacturers to find notified bodies and authorized representatives based in the EU. However, local company SQS remains confident of its ongoing notified body role.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.
With just a few months remaining until the full application of the EU Medical Device Regulation, notified body designations are still only trickling through. Ireland is the latest EU member state to have a resident MDR notified body.